{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:20:35Z","timestamp":1787062835037,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C0070"],"award-info":[{"award-number":["75N93019C0070"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["SHIP-SATBBI"],"award-info":[{"award-number":["SHIP-SATBBI"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SANRF","award":["86535"],"award-info":[{"award-number":["86535"]}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2016CDF1576"],"award-info":[{"award-number":["TMA2016CDF1576"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["NuMeRi Node for Infection Imaging"],"award-info":[{"award-number":["NuMeRi Node for Infection Imaging"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Natural immunity against\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      exists, and\u2009&gt;\u200990% of those infected remain disease-free. Innate and adaptive immune responses required to mediate such protection against tuberculosis (TB) are, however, poorly understood.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This is an analytical study exploring protective and non-protective pathways of immunity against\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      . Adults without HIV infection are recruited at community healthcare clinics in high TB incidence areas of the Western Cape Province, South Africa. Data regarding participants\u2019 medical, social and medication usage will be collected, and clinical examinations and point-of-care tests documented. Reference tests for TB (chest radiographs and sputum tests for GeneXpert MTB\/RIF Ultra\u00ae, Auramine smear and liquid cultures) and investigations to classify infection states [interferon-gamma release assay (IGRA) and SARS-CoV-2 polymerase chain reaction (PCR) nasopharyngeal swab and IgG], are done on all participants who meet the inclusion criteria. 18F-Fluorodeoxyglucose positron emission tomography combined with computerized tomography will be done on all close contacts (contacts) and healthy control (controls) participants. Participants are divided into 12 study groups representing a spectrum of TB clinical phenotypes and prior SARS-CoV-2 infection based on their TB status, exposure history, results of IGRA test at baseline and 3\u00a0months, SARS-CoV-2 serology, and PCR results, and for contacts and controls, PET-CT imaging findings indicative of sub-clinical TB lesions. Samples for experimental assays include whole blood for isolation of peripheral blood mononuclear cells and blood in PAXgene\u00ae tubes for RNA isolation. All SARS-CoV-2 PCR negative study participants undergo bronchoscopy for collecting bronchoalveolar lavage samples.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      The paired blood and BAL samples will be used for comprehensive analyses of the tissue-specific and systemic immunity that will include e.g., cytometry by time-of-flight analyses, RNA-sequencing, multiplex immunoassays, epigenetic analysis, and mechanistic studies of control of infection by\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      . Results will be integrated with those from mice and non-human primate studies to provide a comprehensive analysis of protective pathways in natural and vaccine-induced immunity against\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07349-8","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T10:03:19Z","timestamp":1650016999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6331-9858","authenticated-orcid":false,"given":"Andri\u0451tte M.","family":"Hiemstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice E.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana C.","family":"van Rensburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizna","family":"Maasdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"Mc Anda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"T\u00f6nsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane Alexandra","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Tromp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian D.","family":"van der Spuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B.","family":"Urdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lewinsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Kuivaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelita","family":"Du Plessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanus T.","family":"Malherbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Walzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"key":"7349_CR1","unstructured":"Kasaeva T. WHO global tuberculosis report [Internet]. 2020. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/336069\/9789240013131-eng.pdf."},{"issue":"5","key":"7349_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1164\/rccm.201806-1053PP","volume":"199","author":"S Keshavjee","year":"2019","unstructured":"Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, et al. Moving toward tuberculosis elimination critical issues for research in diagnostics and therapeutics for tuberculosis infection. Am J Respir Crit Care Med. 2019;199(5):564\u201371.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"7349_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrmicro1211","volume":"3","author":"P Andersen","year":"2005","unstructured":"Andersen P, Doherty T. The success and failure of BCG\u2014implications for a novel tuberculosis vaccine. Nat Rev Microbiol. 2005;3(8):656\u201362.","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"7349_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","volume":"18","author":"JD Simmons","year":"2018","unstructured":"Simmons JD, Stein CM, Seshadri C, Campo M, Alter G, Fortune S, et al. Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat Rev Immunol. 2018;18(9):575\u201389. https:\/\/doi.org\/10.1038\/s41577-018-0025-3.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"7349_CR5","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/cid\/cir951","volume":"54","author":"JR Andrews","year":"2012","unstructured":"Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2012;54(6):784\u201391.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7349_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3705-0","volume":"19","author":"JS Molton","year":"2019","unstructured":"Molton JS, Thomas BA, Pang Y, Khor LK, Hallinan J, Naftalin CM, et al. Sub-clinical abnormalities detected by PET\/MRI in household tuberculosis contacts. BMC Infect Dis. 2019;19(1):1\u20137.","journal-title":"BMC Infect Dis"},{"key":"7349_CR7","unstructured":"Vanderbilt. REDcap homepage [Internet]. [cited 2021 Sep 7]. Available from: https:\/\/www.project-redcap.org\/."},{"issue":"1","key":"7349_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.5195\/jmla.2018.319","volume":"106","author":"EF Partridge","year":"2018","unstructured":"Partridge EF, Bardyn TP. Research electronic data capture (REDCap). J Med Libr Assoc. 2018;106(1):142\u20134. https:\/\/doi.org\/10.5195\/jmla.2018.319.","journal-title":"J Med Libr Assoc"},{"key":"7349_CR9","unstructured":"Medicine and Health Sciences Stellenbosch University. Biomedical Research Institute Biorepository Unit [Internet]. Stellenbosch University. 2021 [cited 2021 Jul 9]. p. Biorepository. Available from: http:\/\/www.sun.ac.za\/english\/faculty\/healthsciences\/biorepository."},{"key":"7349_CR10","unstructured":"Otterman B. BMRI Research Bronchoscopy Suite unlocks major research opportunities [Internet]. VIVUS. [cited 2021 Sep 7]. Available from: http:\/\/www0.sun.ac.za\/vivus\/vivus-1-march-2021\/innovation\/bmri-research-bronchoscopy-suite-unlocks-major-research-opportunities.html."},{"issue":"1","key":"7349_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41231-019-0039-2","volume":"4","author":"C Young","year":"2019","unstructured":"Young C, Ahlers P, Hiemstra AM, Loxton AG, Gutschmidt A, Malherbe ST, et al. Performance and immune characteristics of bronchoalveolar lavage by research bronchoscopy in pulmonary tuberculosis and other lung diseases in the Western Cape, South Africa. Transl Med Commun. 2019;4(1):1\u201312.","journal-title":"Transl Med Commun"},{"key":"7349_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203618","author":"IA Du Rand","year":"2013","unstructured":"Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults. Thorax. 2013. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-203618.","journal-title":"Thorax"},{"issue":"1","key":"7349_CR13","first-page":"8","volume":"71","author":"N Facciolongo","year":"2009","unstructured":"Facciolongo N, Patelli M, Gasparini S, Agli LL, Salio M, Simonassi C, et al. Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopies. Monaldi Arch Chest Dis. 2009;71(1):8\u201314.","journal-title":"Monaldi Arch Chest Dis"},{"issue":"4","key":"7349_CR14","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1378\/chest.104.4.1296","volume":"104","author":"JW De Fijter","year":"1993","unstructured":"De Fijter JW, Van der Hoeven JG, Eggelmeijer F, Meinders AE. Sepsis syndrome and death after bronchoalveolar lavage. Chest. 1993;104(4):1296\u20137.","journal-title":"Chest"},{"issue":"1","key":"7349_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/LBR.0b013e3182426243","volume":"19","author":"S Patolia","year":"2012","unstructured":"Patolia S, Zahir M, Schmidt F, Enriquez D, Quist J, Gulati N, et al. Bilateral pneumothorax after bronchoscopy without biopsy\u2014a rare complication: case presentation and literature review. J Bronchol Interv Pulmonol. 2012;19(1):57\u201360.","journal-title":"J Bronchol Interv Pulmonol"},{"key":"7349_CR16","unstructured":"Cental Analytical Facilities Stellenbosch University. NuMeRI Node for Infection Imaging\u2014PET-CT Scanner [Internet]. Stellenbosch University. 2021 [cited 2021 Jul 9]. p. Units\/Laboratories. Available from: http:\/\/www.sun.ac.za\/english\/faculty\/science\/CAF\/units\/pet-ct-scanner."},{"key":"7349_CR17","unstructured":"European Association of Nuclear Medicine. EARL FDG-PET\/CT accreditation programme [Internet]. Research4Life. 2021 [cited 2021 Jul 9]. p. Centres for excellence network. Available from: https:\/\/earl.eanm.org\/centres-of-excellence-network\/."},{"issue":"6","key":"7349_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/09553000902883836","volume":"85","author":"ES Gilbert","year":"2009","unstructured":"Gilbert ES. Ionising radiation and cancer risks: what have we learned from epidemiology? Int J Radiat Biol. 2009;85(6):467\u201382.","journal-title":"Int J Radiat Biol"},{"key":"7349_CR19","unstructured":"Stellenbosch University Medicine and Health. Biomedical Research Institute Biorepository Unit [Internet]. [cited 2021 Sep 7]. Available from: http:\/\/www.sun.ac.za\/english\/faculty\/healthsciences\/biorepository."},{"issue":"2","key":"7349_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/biostatistics\/kxm030","volume":"9","author":"MD Robinson","year":"2008","unstructured":"Robinson MD, Smyth GK. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics. 2008;9(2):321\u201332.","journal-title":"Biostatistics"},{"key":"7349_CR21","doi-asserted-by":"crossref","unstructured":"Kaipilyawar V, Salgame P. Infection resisters: targets of new research for uncovering natural protective immunity against Mycobacterium tuberculosis. F1000Research. 2019; 8:1\u201313.","DOI":"10.12688\/f1000research.19805.1"},{"issue":"October","key":"7349_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.I5770","volume":"367","author":"MA Behr","year":"2019","unstructured":"Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ. 2019;367(October):1\u20137. https:\/\/doi.org\/10.1136\/bmj.I5770.","journal-title":"BMJ"},{"issue":"3","key":"7349_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nrmicro2236-c1","volume":"8","author":"M Pai","year":"2010","unstructured":"Pai M. Spectrum of latent tuberculosis existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol. 2010;8(3):242.","journal-title":"Nat Rev Microbiol"},{"key":"7349_CR24","unstructured":"National Institute of Allergy and Infectious Diseases. ImmPort bioinformatics for the future of immunology [Internet]. [cited 2021 Sep 7]. Available from: https:\/\/www.immport.org\/home."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07349-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T11:03:21Z","timestamp":1650107001000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07349-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7349"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07349-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"14 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study is being performed in accordance with the Declaration of Helsinki and it was approved by the Health Research Ethics Committee of Stellenbosch University (Ref No. REC-130408-012) with a Federal Wide Assurance No. 00001372; IRB 0005240; Study No N19\/10\/150. The main site of Cascade IMPAc-TB, Seattle Children\u2019s Research Institute, received IRB approval for the study (STUDY00002411) on Nov 3, 2020. Written informed consent is obtained from all study participants before they are enrolled in the study. No prisoners or children are recruited into the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"381"}}